These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33813046)

  • 61. [Post-traumatic stress disorder in reaction to psychotic experience: A systematic revue].
    Galliot G; Very E; Schmitt L; Rouch V; Salles J
    Encephale; 2019 Dec; 45(6):506-512. PubMed ID: 31521338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of childhood adversities on specific symptom dimensions in first-episode psychosis.
    Ajnakina O; Trotta A; Oakley-Hannibal E; Di Forti M; Stilo SA; Kolliakou A; Gardner-Sood P; Gaughran F; David AS; Dazzan P; Pariante C; Mondelli V; Morgan C; Vassos E; Murray RM; Fisher HL
    Psychol Med; 2016 Jan; 46(2):317-26. PubMed ID: 26383785
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patterns of cranial, brain and sulcal CSF volumes in male and female deficit and nondeficit patients with schizophrenia.
    Arango C; McMahon RP; Lefkowitz DM; Pearlson G; Kirkpatrick B; Buchanan RW
    Psychiatry Res; 2008 Feb; 162(2):91-100. PubMed ID: 18201875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A five-year followup study of deficit and nondeficit schizophrenia.
    Tek C; Kirkpatrick B; Buchanan RW
    Schizophr Res; 2001 Apr; 49(3):253-60. PubMed ID: 11356586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progressive brain structural changes after the first year of treatment in first-episode treatment-naive patients with deficit or nondeficit schizophrenia.
    Lei W; Kirkpatrick B; Wang Q; Deng W; Li M; Guo W; Liang S; Li Y; Zhang C; Li X; Zhang P; Li Z; Xiang B; Chen J; Hu X; Zhang N; Li T
    Psychiatry Res Neuroimaging; 2019 Jun; 288():12-20. PubMed ID: 31059954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation.
    Wagman AM; Heinrichs DW; Carpenter WT
    Psychiatry Res; 1987 Dec; 22(4):319-30. PubMed ID: 3432456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Executive function in deficit schizophrenia: what do the dimensions of the Wisconsin Card Sorting Test tell us?
    Polgár P; Réthelyi JM; Bálint S; Komlósi S; Czobor P; Bitter I
    Schizophr Res; 2010 Sep; 122(1-3):85-93. PubMed ID: 20627227
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia.
    Podwalski P; Tyburski E; Szczygieł K; Rudkowski K; Waszczuk K; Andrusewicz W; Kucharska-Mazur J; Michalczyk A; Mak M; Cyranka K; Misiak B; Sagan L; Samochowiec J
    Brain Sci; 2022 Feb; 12(2):. PubMed ID: 35204030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
    Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
    Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.
    Inchausti L; Gorostiza I; Gonzalez Torres MA; Oraa R
    Psychiatry Res; 2023 Oct; 328():115475. PubMed ID: 37713923
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia.
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Pays M; Petit M
    Biol Psychiatry; 1994 Aug; 36(4):230-6. PubMed ID: 7986887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study.
    Erzin G; Pries LK; Dimitrakopoulos S; Ralli I; Xenaki LA; Soldatos RF; Vlachos I; Selakovic M; Foteli S; Kosteletos I; Nianiakas N; Mantonakis L; Rizos E; Kollias K; Van Os J; Guloksuz S; Stefanis N
    Psychol Med; 2023 Apr; 53(6):2609-2618. PubMed ID: 34789350
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Relationship between Alcohol-Cannabis Use and Stressful Events with the Development of Incident Clinical Psychosis in a Community-Based Prospective Cohort.
    Kirli U; Binbay T; Alptekin K; Kayahan B; Elbi H
    Turk Psikiyatri Derg; 2021; 32(4):235-245. PubMed ID: 34964097
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Not Available].
    Pérez Benítez CI; Vicente B; Zlotnick C; Kohn R; Johnson J; Valdivia S; Rioseco P
    Salud Ment (Mex); 2009 Jan; 32(2):145-153. PubMed ID: 21113425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
    Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
    Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.